Home Genzyme Corporate Research Search Genzyme Websites
Patients and FamiliesHealth Care Professionals
Pediatric acute lymphoblastic leukemia patient In pediatric relapsed or refractory acute lymphoblastic leukemia respond with Clolar Clolar clofarabine for intravenous infusion
Site Map
Patients and Families

Disease Overview Treatment Challenges
Clolar Facts How Clolar Works
Chemotherapy Facts What to Expect with Clolar
Caring for Your Child Caring for Yourself
Caring for Your Family Talking With Your Doctor
Talking with Family and Friends Direct Response Program
Clolar Collaborative Support Materials
Ask Us Advocacy and Support Groups
Useful Links Your Response Matters
Glossary Clinical Studies
Clolar Profiles Prescribing Information
About Genzyme Oncology
Healthcare Professionals

Treatment Challenges Second Generation PNA
Dual Mechanism of Action Pharmacokinetics
Study Data Selected Publications
Response Rates Case Studies
Dosing FAQs
Ongoing Trials Treatment Considerations
Patient Monitoring Considerations Patient/Caregiver Considerations
Adverse Events Direct Response Program
Clolar Collaborative Support Materials
Events Useful Links
Your Response Matters Email Updates
Prescribing Information About Genzyme Oncology
Clolar.com

Home Terms and Conditions of Use
Search Privacy Policy
Contact Us
Search Clolar
Search in:
Contact Information
Genzyme Oncology
500 Kendall Street
Cambridge, MA 02142
1-800-792-5652
Contact Us
Full Prescribing Information
Terms and Conditions of Use | Privacy Policy | Site Map | This site is intended for United States residents only.
© 2008 Genzyme Corporation. All rights reserved. Clolar® is a registered trademark and A chance to respond™
is a trademark of Genzyme Corporation.
Genzyme